India Reports Evolving Mpox Strain Linked to Kerala Cases

Indian researchers have identified a genetically distinct Mpox (monkeypox) strain, Clade Ib, in recent cases from Kerala. The study suggests the virus may have been circulating earlier than previously thought and shows patterns of sustained human-to-human transmission, highlighting the importance of ongoing surveillance and preparedness in infectious disease control.

Source: Times of India (The Times of India)

`National Health Authority (NHA) Advances Multilingual Digital Health & AI Initiatives`

The National Health Authority inked multiple MoUs to scale digital health and AI innovationsunder Ayushman Bharat Pradhan Mantri Jan Arogya Yojana (AB-PMJAY). The agreements aim to integrate multilingual digital tools, improve beneficiary experience, and strengthen tech-enabled health delivery across states.

Source: Medical Buyer (Medical Buyer)

`Karnataka Organisations Rally Against High Private Hospital Costs`

Thirty-five civic and health groups in Karnataka announced a statewide demonstration titled “Jatha for Right to Health” (Feb 2–27, 2026), protesting excessive private healthcare costs and lack of free medicines in government hospitals — a major public push for affordable and equitable care.

Source: Times of India (The Times of India)

`India’s Healthcare Policy Now Shifts to ‘Wellness’ Focus`

Union Minister Anupriya Patel announced a reorientation of India’s national health policy from traditional “sick care” toward wellness and preventive health, marking the first significant national policy update in 15 years. The move emphasizes lifestyle interventions, early screening, and holistic well-being.

Source: Times of India (The Times of India)

`Kauvery Hospital Honoured Among India’s Most Preferred Healthcare Workplaces`

Kauvery Hospital has been recognised as one of India’s Most Preferred Workplaces 2025-26in the healthcare sector, highlighting the institution’s strong work culture, employee engagement, and leadership practices.

Source: Business Standard / ANI (Business Standard)

`AI Must Translate Innovation into Population Health Impact — Experts`

At the Reimagining AI in Healthcare pre-summit in Hyderabad, experts emphasised that while AI has advanced in drug discovery and genomics, its real value must translate into tangible population health improvementssuch as disease surveillance, rural outreach and health literacy.

Source: Times of India (The Times of India)

`AstraZeneca to Delist ADRs from Nasdaq, Move to NYSE`

Pharma giant AstraZeneca announced plans to delist its American Depositary Shares and debt securities from Nasdaqand list exclusively on the New York Stock Exchange (NYSE) in February, a strategic move to align its capital markets presence.

Source: Reuters (Reuters)

`Johnson & Johnson Hits Record Highs Despite Challenges`

Johnson & Johnson continues to trade at historic valuation heights, even as the company navigates legal headwinds and accelerates med-tech transformation, reflecting investor confidence in diversified healthcare portfolios.

Source: MarketMinute / FinancialContent (FinancialContent)

📌 Daily Pulse Insight

✔ Infectious disease dynamicsare evolving — India’s Mpox findings stress ongoing vigilance.

✔ Digital health innovationunder AB-PMJAY is advancing with AI and multilingual tools.

✔ Affordability and accessremain core public concerns, with civic action rising.

✔ Policy horizons are shiftingtoward preventive wellness over reactive care.

✔ Recognition of workplaces in healthcare signals talent-centric growth.

✔ AI’s role is increasingly about population impact, not just technology.

✔ Global healthcare industry dynamics (AstraZeneca, J&J) continue shifting investor and strategic frames.

✨ Follow Daily Pulse for concise, credible, and timely healthcare & pharma insights every day. #DailyPulse #IndiaHealthcare #PharmaNews #PublicHealth #DigitalHealth #AIinHealth #HealthPolicy #InfectiousDiseases

Disclaimer: The views and opinions expressed in this interview are those of the author and do not reflect the official position of any medical body or organization. 
The author is not a medical doctor; however, the insights shared are based on over a decade of working experience in the healthcare sector start-ups. 
Readers should consult with a qualified healthcare professional for medical advice or information related to their specific situation.

Please follow our page Aristocrat Media for more updates 
For Enquiries connect us on:
marketing@aristocrat-media.com